摘要
目的 分析阿莫西林和奥美拉唑联合用于胃溃疡的价值。方法 对2020年10月-2022年6月本科接诊胃溃疡病人(n=86)进行随机分组,试验和对照组各43人,前者用阿莫西林和奥美拉唑,后者用奥美拉唑。对比不良反应等指标。结果 关于不良反应,试验组数据2.33%,和对照组数据20.93%相比更低(P<0.05)。关于总有效率这个指标:试验组数据97.67%,和对照组数据81.4%相比更高(P<0.05)。关于Hp根除率,试验组数据93.02%,和对照组数据72.09%相比更高(P<0.05)。关于sf-36评分,治疗结束时:试验组数据(87.31±2.58)分,和对照组数据(80.53±3.91)分相比更高(P<0.05)。关于复发率,试验组数据0.0%,和对照组数据11.63%相比更低(P<0.05)。结论 胃溃疡联用阿莫西林和奥美拉唑,不良反应发生率更低,Hp根除率更高,复发率也更低,生活质量改善更加明显,疗效提升更为迅速。
关键词: 胃溃疡;不良反应;阿莫西林;疗效;奥美拉唑
Abstract
Objective: To analyze the value of amoxicillin and omeprazole combined for gastric ulcer. Methods: Patients with gastric ulcer (n=86) from October 2020 to June 2022 were randomized, with 43 patients in the control group with amoxicillin and omeprazole and the latter with omeprazole. Contrast the adverse reactions and other indicators. Results: Regarding the adverse reactions, the test group data was 2.33%, which was even lower than the 20.93% data in the control group (P <0.05). On total response efficiency: 97.67% in the test group, higher than 81.4% in the control group (P <0.05). Regarding the Hp eradication rate, the test group data was 93.02%, and it was higher than the 72.09% data in the control group (P <0.05). For the sf-36 score, at the end of treatment: the trial group data (87.31 ± 2.58) score was higher than the control group data (80.53 ± 3.91) score (P <0.05). Regarding the recurrence rate, the trial group data was 0.0%, which was lower than the control group data of 11.63% (P <0.05). Conclusion : Amoxicillin and omeprazole have a lower incidence of adverse reactions, higher Hp eradication rate, lower recurrence rate, more significantly improved quality of life, and more rapid improvement of efficacy.
Key words: Gastric Ulcer; Adverse Reactions; Amoxicillin; Efficacy; Omeprazole
参考文献 References
[1] 李想,王晓娜. 雷贝拉唑与奥美拉唑分别联合克拉霉素、阿莫西林治疗胃溃疡的临床对比研究[J]. 罕少疾病杂志,2022,29(2):74-75.
[2] 谢惠娟. 奥美拉唑、阿莫西林、克拉霉素三联治疗幽门螺杆菌阳性胃溃疡患者的疗效与安全性[J]. 临床合理用药杂志,2022,15(23):63-66.
[3] 陈泰来. 奥美拉唑联合阿莫西林克拉霉素对Hp阳性胃溃疡患者溃疡愈合情况及Hp根除率的影响[J]. 基层医学论坛,2021,25(5):714,720.
[4] 黎勇强. 奥美拉唑联合阿莫西林治疗胃炎并胃溃疡的临床治疗有效性和安全性分析[J]. 当代医学,2021, 27(8):136-138.
[5] 杨勇. 奥美拉唑结合阿莫西林治疗胃炎并胃溃疡的疗效及对Hp感染根除率的影响[J]. 医学食疗与健康,2021, 19(4):60-61.
[6] 黄运梅. 分析胃炎并胃溃疡患者采用奥美拉唑联合阿莫西林治疗的临床效果[J]. 中国社区医师,2021, 37(24):71-72.
[7] 安茹. 奥美拉唑与阿莫西林联合克拉霉素三联疗法综合治疗胃溃疡的临床效果观察[J]. 健康之友, 2021 (8):15.
[8] 史艳伟. 奥美拉唑、克拉霉素和阿莫西林三联用药治疗幽门螺杆菌相关性胃溃疡的效果[J]. 临床医学,2021, 41(8):102-103.
[9] 闫文校,郑晗. 观察奥美拉唑和泮托拉唑分别联合阿莫西林治疗胃溃疡的治疗效果[J]. 中国保健营养,2021,31(22):134.
[10] 陈相君. 艾司奥美拉唑和兰索拉唑联合阿莫西林治疗胃溃疡的临床效果对比[J]. 中国实用医药,2021,16(34): 33-36.
[11] 郭钢. 胃溃疡联合应用奥美拉唑与阿莫西林治疗的临床价值对比分析[J]. 中国医药指南,2020,18(20): 153-154,157.